Shanna Miranti, MPAS, PA-C, Shares Highlights From Diversity in Dermatology Meeting
Miranti presented tips on handling denial hurdles and how to ensure patients receive access to the treatments they need.
Gaining Access to Roflumilast Foam and Cabtreo in 2024
Shanna Miranti, MPAS, PA-C, shares updates on the status of roflumilast foam 0.3% and Cabtreo available in US pharmacies.
October Pipeline Preview
Aaron Farberg, MD, and Shanna Miranti, MPAS, PA-C, discuss the upcoming approvals of nivolumab and IDP-126.
VP-102 Now Approved for the Treatment of Molluscum Contagiosum
Verrica’s VP-102 is the first FDA-approved treatment for molluscum lesions.
The Role of Dermatology Advanced Practice Providers With Shanna Miranti, PA-C
Dermatology advanced practice providers work alongside physicians to improve patient care and access.